26.06.2017 15:27:00
|
Sinovac Biotech To Be Acquired By Parent For Around $401.8 Mln
(RTTNews) - Sinovac Biotech Ltd. (SVA) Monday said it has entered into a definitive amalgamation agreement with the parent Sinovac (Cayman) Limited and Sinovac Amalgamation Sub Limited to be acquired by Parent in a transaction valued at approximately $401.8 million.
Pursuant to the Amalgamation Agreement, Parent will acquire Sinovac Biotech for cash consideration equal to $7.00 per common share. This represents a premium of 32.1 percent and 30 percent, respectively, over the Company's 30- and 60-trading day volume-weighted average price.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sinovac Biotech LtdShsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sinovac Biotech LtdShsmehr Analysen
Aktien in diesem Artikel
Sinovac Biotech LtdShs | 6,47 | -0,31% |
|